The DOI matches its Crossref record.
A Stapled Peptide Mimic of the Pseudosubstrate Inhibitor PKI Inhibits Protein Kinase A
Abstract
Kinases regulate multiple and diverse signaling pathways and misregulation is implicated in a multitude of diseases. Although significant efforts have been put forth to develop kinase-specific inhibitors, specificity remains a challenge. As an alternative to catalytic inhibition, allosteric inhibitors can target areas on the surface of an enzyme, thereby providing additional target diversity. Using cAMP-dependent protein kinase A (PKA) as a model system, we sought to develop a hydrocarbon-stapled peptide targeting the pseudosubstrate domain of the kinase. A library of peptides was designed from a Protein Kinase Inhibitor (PKI), a naturally encoded protein that serves as a pseudosubstrate inhibitor for PKA. The binding properties of these peptide analogs were characterized by fluorescence polarization and surface plasmon resonance, and two compounds were identified with KD values in the 500–600 pM range. In kinase activity assays, both compounds demonstrated inhibition with 25–35 nM IC50 values. They were also found to permeate cells and localize within the cytoplasm and inhibited PKA activity within the cellular environment. To the best of our knowledge, these stapled peptide inhibitors represent some of the highest affinity binders reported to date for hydrocarbon stapled peptides.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An example is the stapled peptide version of IP20 that penetrates cells and has a low nM affinity 88.”
From Edmond Fischer's kinase legacy: History of the protein kinase inhibitor and protein kinase A (2023) · cites this paper as [88]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 36
- Manning, 2002, The protein kinase complement of the human genome, Science, 298, 1912, 10.1126/science.1075762 · DOI · Paper page
- Brognard, 2011, Protein kinase signaling networks in cancer, Curr. Opin. Genet. Dev., 21, 4, 10.1016/j.gde.2010.10.012 · DOI · Paper page
- Ferguson, 2018, Kinase inhibitors: The road ahead, Nat. Rev. Drug Discov., 17, 353, 10.1038/nrd.2018.21 · DOI · Paper page
- Muller, 2015, The ins and outs of selective kinase inhibitor development, Nat. Chem. Biol., 11, 818, 10.1038/nchembio.1938 · DOI · Paper page
- Zhang, 2009, Targeting cancer with small molecule kinase inhibitors, Nat. Rev. Cancer, 9, 28, 10.1038/nrc2559 · DOI · Paper page
- Taylor, 2013, PKA: Lessons learned after twenty years, Biochim. Biophys. Acta, 1834, 1271, 10.1016/j.bbapap.2013.03.007 · DOI · Paper page
- Taylor, 2012, Assembly of allosteric macromolecular switches: Lessons from PKA, Nat. Rev. Mol. Cell Biol., 13, 646, 10.1038/nrm3432 · DOI · Paper page
- Kemp, 1990, Protein kinase recognition sequence motifs, Trends Biochem. Sci., 15, 342, 10.1016/0968-0004(90)90073-K · DOI · Paper page
- Walsh, 1971, Krebs EG: Purification and characterization of a protein inhibitor of adenosine 3’,5’-monophosphate-dependent protein kinases, J. Biol. Chem., 246, 1977, 10.1016/S0021-9258(19)77177-4 · DOI · Paper page
- Scott, 1985, Identification of an inhibitory region of the heat-stable protein inhibitor of the cAMP-dependent protein kinase, Proc. Natl. Acad. Sci. USA, 82, 4379, 10.1073/pnas.82.13.4379 · DOI · Paper page
- Scott, 1985, Amino acid sequence of the heat-stable inhibitor of the cAMP-dependent protein kinase from rabbit skeletal muscle, Proc. Natl. Acad. Sci. USA, 82, 5732, 10.1073/pnas.82.17.5732 · DOI · Paper page
- Scott, 1986, Primary-structure requirements for inhibition by the heat-stable inhibitor of the cAMP-dependent protein kinase, Proc. Natl. Acad. Sci. USA, 83, 1613, 10.1073/pnas.83.6.1613 · DOI · Paper page
- Cheng, 1985, An active twenty-amino-acid-residue peptide derived from the inhibitor protein of the cyclic AMP-dependent protein kinase, Biochem. J., 231, 655, 10.1042/bj2310655 · DOI · Paper page
- Whitehouse, 1983, Mg X ATP2-dependent interaction of the inhibitor protein of the cAMP-dependent protein kinase with the catalytic subunit, J. Biol. Chem., 258, 3682, 10.1016/S0021-9258(18)32719-4 · DOI · Paper page
- Glass, 1989, Primary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor protein, J. Biol. Chem., 264, 8802, 10.1016/S0021-9258(18)81864-6 · DOI · Paper page
- Eichholtz, 1993, A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitor, J. Biol. Chem., 268, 1982, 10.1016/S0021-9258(18)53951-X · DOI
- Knighton, 1991, Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase, Science, 253, 407, 10.1126/science.1862342 · DOI · Paper page
- Knape, 2017, Divalent metal ions control activity and inhibition of protein kinases, Metallomics, 9, 1576, 10.1039/C7MT00204A · doi:10.1039/c7mt00204a
- Lochner, 2006, The many faces of H89: A review, Cardiovasc Drug Rev., 24, 261, 10.1111/j.1527-3466.2006.00261.x · DOI · Paper page
- Davies, 2000, Specificity and mechanism of action of some commonly used protein kinase inhibitors, Biochem. J., 351, 95, 10.1042/bj3510095 · DOI · Paper page
- Mitchell, 1995, Heat-stable inhibitor protein derived peptide substrate analogs: Phosphorylation by cAMP-dependent and cGMP-dependent protein kinases, Biochemistry, 34, 528, 10.1021/bi00002a018 · DOI
- Viht, 2007, Surface-plasmon-resonance-based biosensor with immobilized bisubstrate analog inhibitor for the determination of affinities of ATP- and protein-competitive ligands of cAMP-dependent protein kinase, Anal. Biochem., 362, 268, 10.1016/j.ab.2006.12.041 · doi:10.1016/j.ab.2006.12.041
- Ivan, 2016, Bifunctional Ligands for Inhibition of Tight-Binding Protein-Protein Interactions, Bioconjug. Chem., 27, 1900, 10.1021/acs.bioconjchem.6b00293 · DOI
- Hanold, 2017, Targeting kinase signaling pathways with constrained peptide scaffolds, Pharmacol. Ther., 173, 159, 10.1016/j.pharmthera.2017.02.014 · DOI
- Fulton, 2018, Conformationally constrained peptides target the allosteric kinase dimer interface and inhibit EGFR activation, Bioorg. Med. Chem., 26, 1167, 10.1016/j.bmc.2017.08.051 · DOI
- Flaherty, B.R., Ho, T.G., Schmidt, S.H., Herberg, F.W., Peterson, D.S., and Kennedy, E.J. (2019). Targeted Inhibition of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 with a Constrained J Domain-Derived Disruptor Peptide. ACS Infect. Dis. · doi:10.1021/acsinfecdis.8b00347
- Hill, 2014, Constraining cyclic peptides to mimic protein structure motifs, Angew. Chem. Int. Ed. Engl., 53, 13020, 10.1002/anie.201401058 · DOI · Paper page
- Zimmermann, 2008, Effect of metal ions on high-affinity binding of pseudosubstrate inhibitors to PKA, Biochem. J., 413, 93, 10.1042/BJ20071665 · DOI · Paper page
- Hanold, L.E., Oruganty, K., Ton, N.T., Beedle, A.M., Kannan, N., and Kennedy, E.J. (2015). Inhibiting EGFR dimerization using triazolyl-bridged dimerization arm mimics. PLoS ONE, 10. · DOI
- Olsen, 1989, Affinity purification of the C alpha and C beta isoforms of the catalytic subunit of cAMP-dependent protein kinase, J. Biol. Chem., 264, 18662, 10.1016/S0021-9258(18)51518-0 · DOI
- Thomas, 1991, Expression in Escherichia coli and characterization of the heat-stable inhibitor of the cAMP-dependent protein kinase, J. Biol. Chem., 266, 10906, 10.1016/S0021-9258(18)99105-2 · doi:10.1016/s0021-9258(18)99105-2
- Saldanha, 2006, Assay principle for modulators of protein-protein interactions and its application to non-ATP-competitive ligands targeting protein kinase A, Anal. Chem., 78, 8265, 10.1021/ac061104g · DOI
- Bendzunas, N.G., Dorfler, S., Autenrieth, K., Bertinetti, D., Machal, E.M.F., Kennedy, E.J., and Herberg, F.W. (2018). Investigating PKA-RII specificity using analogs of the PKA:AKAP peptide inhibitor STAD-2. Bioorg. Med. Chem. · doi:10.1016/j.bmc.2018.02.001
- Knape, 2015, Divalent Metal Ions Mg(2)(+) and Ca(2)(+) Have Distinct Effects on Protein Kinase A Activity and Regulation, ACS Chem. Biol., 10, 2303, 10.1021/acschembio.5b00271 · doi:10.1021/acschembio.5b00271
- Huang, 2014, Structural basis for cyclic-nucleotide selectivity and cGMP-selective activation of PKG I, Structure, 22, 116, 10.1016/j.str.2013.09.021 · DOI
- Zimmermann, 1999, PrKX Is a Novel Catalytic Subunit of the cAMP-dependent Protein Kinase Regulated by the Regulatory Subunit Type I, J. Biol. Chem., 274, 5370, 10.1074/jbc.274.9.5370 · DOI
Cited by
Edmond Fischer's kinase legacy: History of the protein kinase inhibitor and protein kinase A
Taylor, S. S., Herberg, F. W., Veglia, G., & Wu, J. (2023) · IUBMB Life · doi:10.1002/iub.2714 · Cited by 15
Self-citation
Metadata
- Authors
- Manschwetus, J. T., Bendzunas, G. N., Limaye, A. J., Knape, M. J., Herberg, F. W., & Kennedy, E. J.
- Affiliations
- Department of Biochemistry, Institute for Biology, University of Kassel, Heinrich-Plett-Str. 40, 34132 Kassel, Germany
- Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, 240 W. Green St, Athens, GA 30602, USA
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2019-04-20
- Volume
- 24
- Issue
- 8
- Pages
- 1567
- ISSN
- 1420-3049
- Cited by
- 17
- References
- 0
- Language
- en
- Funders
- National Institutes of Health (CA154600, CA188439)
- U.S. Department of Defense (W81XWH-17-1-0290)
- Deutsche Forschungsgemeinschaft (He1818/10)
- PhosMOrg (Future)
- Otto-Braun Fund (Predoctoral Fellowship)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Stapled Peptide Mimic of the Pseudosubstrate Inhibitor PKI Inhibits Protein Kinase A. https://app.cochat.ai/papers/10.3390/molecules24081567
- The paper
- Manschwetus, J. T., Bendzunas, G. N., Limaye, A. J., Knape, M. J., Herberg, F. W., & Kennedy, E. J. (2019). A Stapled Peptide Mimic of the Pseudosubstrate Inhibitor PKI Inhibits Protein Kinase A. Molecules. https://doi.org/10.3390/molecules24081567
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.